SLNO
Soleno Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SLNO fundamentals
Soleno Therapeutics (SLNO) released its earnings on Nov 4, 2025: revenue was 66.00M (YoY 0.00%), beat estimates; EPS was 0.47 (YoY +125.68%), beat estimates.
Revenue / YoY
66.00M
0.00%
EPS / YoY
0.47
+125.68%
Report date
Nov 4, 2025
SLNO Earnings Call Summary for Q3,2025
- Revenue milestone: Q3 2025 net revenue doubles to $66 million, marking first profitable quarter.
- Market adoption: 764 active patients on VYKAT XR, 494 prescribers, and 132 million lives covered by payers.
- Discontinuation management: 8% AE-related discontinuations, with efforts to restart therapy through patient education.
- Global expansion: EU regulatory progress for 9,500 PWS patients, despite ongoing U.S. launch.
- Financial strength: $556 million cash balance supports commercialization and international expansion.
EPS
Revenue
Revenue & Expenses
SLNO has released its 2025 Q3 earnings report, with revenue of 66.02M, reflecting a YoY change of NaN%, and net profit of 26.01M, showing a YoY change of 133.95%. The Sankey diagram below clearly presents SLNO's revenue sources and cost distribution.
Key Indicators
Soleno Therapeutics (SLNO) key financial stats and ratios, covering profitability, financial health, and leverage.
Soleno Therapeutics (SLNO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Soleno Therapeutics (SLNO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Soleno Therapeutics (SLNO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Soleno Therapeutics (SLNO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Soleno Therapeutics (SLNO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Soleno Therapeutics’s earnings call?What is Soleno Therapeutics's latest dividend and current dividend yield?What guidance did Soleno Therapeutics's management provide for the next earnings period?What does Soleno Therapeutics do and what are its main business segments?What were the key takeaways from Soleno Therapeutics's earnings call?What factors drove the changes in Soleno Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Soleno Therapeutics year over year?What is Soleno Therapeutics's gross profit margin?
